Heart Failure Clinical Trial

Evaluation of Left Ventricular AutoThreshold

Summary

This study will collect data on a new feature for future heart failure devices via an external non-implantable system.

View Full Description

Full Description

ELEVATE is an acute, prospective, multi-center, feasibility study with a randomized within patient test sequence and pulse width, designed to characterize the performance of the Left Ventricular Auto Threshold feature.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients who are scheduled to receive a CRT-P or CRT-D, based on physician discretion
Patients who are willing and capable of participating in all testing associated with this study
Patients who are 18 or above, or of legal age to give informed consent specific to state and national law

Exclusion Criteria:

Patients who have, or are scheduled to receive a unipolar LV pace/sense lead to be used with the CRT-P/CRT-D device, unless the patient has any commercially available epicardial leads with at least two electrodes (from one or more leads)
Patients with pre-existing leads other than those specified in this investigational plan (unless the Investigator intends to replace them with permitted leads)
Patients with a pre-existing unipolar pacemaker that will not be explanted/abandoned
Patients enrolled in any concurrent study, without Boston Scientific CRM written approval, that may confound the results of this study
Patients with a prosthetic mechanical tricuspid heart valve
Women who are pregnant

Study is for people with:

Heart Failure

Estimated Enrollment:

80

Study ID:

NCT00812201

Recruitment Status:

Completed

Sponsor:

Boston Scientific Corporation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Virginia Commonwealth University Health System
Richmond Virginia, 23298, United States
Monongalia General Hospital
Morgantown West Virginia, 26505, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

80

Study ID:

NCT00812201

Recruitment Status:

Completed

Sponsor:


Boston Scientific Corporation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider